AMPICILLIN SODIUM FOR INJECTION, USP
TEVA CANADA LIMITED
Quick answers
Is there a shortage of AMPICILLIN SODIUM FOR INJECTION, USP in Canada?
No. There is no current shortage of AMPICILLIN SODIUM FOR INJECTION, USP 2G reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
AMPICIN INJ 2000MG
BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB
Other Products
PENBRITIN INJ 2000MG
AYERST LABORATORIES
AMPICIN INJ 1GM
BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB
PENBRITIN INJ 1000MG
AYERST LABORATORIES
AMPICIN INJ 500MG
BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB
AMPICIN INJ 125MG/VIAL
BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB
DIN
01933353
Strength
2G
Dosage Form
Powder For Solution
Route
Intravenous Intramuscular
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646